Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 8, 2011, Pages 950-954

  Ben Amitai, D ^a   Laron, Z ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

acne; androgens; growth hormone; IGF 1; IGF 1 deficiency; Laron syndrome

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT SOMATOMEDIN C; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ACNE VULGARIS; ADOLESCENT; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY; LARON SYNDROME; LUTEINIZING HORMONE BLOOD LEVEL; MALE; OLIGOAMENORRHEA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PUBERTY; TESTOSTERONE BLOOD LEVEL;

ACNE VULGARIS; ADOLESCENT; ADULT; ANDROSTENEDIONE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; LUTEINIZING HORMONE; MALE; TESTOSTERONE; YOUNG ADULT;

EID: 79960286182     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03896.x     Document Type: Article

References (36)

1. Thiboutot D,. Acne: an overview of clinical research findings. Dermatol Clin 1997; 15: 97-109. (Pubitemid 27034658)
2. Laron Z, Pertzelan A, Manheimer S,. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr Med J 1966; 2: 153-155.
3. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J,. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994; 15: 369-390. (Pubitemid 24180794)
4. Laron Z,. Laron syndrome-Primary growth hormone resistance. In, Jameson JL, ed. Contemporary Endocrinology, Hormone Resistance Syndromes, Vol. 2. Human Press, Totowa, 1999: 17-37.
5. Laron Z,. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab 2004; 89: 1031-1044. (Pubitemid 38368385)
6. Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, Daughaday WH,. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 1971; 33: 332-342.
7. Laron Z, Sarel R, Pertzelan A,. Puberty in Laron type dwarfism. Eur J Pediatr 1980; 134: 79-83.
8. Laron Z,. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity). Pediatr Endocrinol Rev 2008; 5: 766-771. (Pubitemid 351462140)
9. Hodak E, Gottlieb AB, Anzilotti M, Krueger JG,. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J Invest Dermatol 1996; 106: 564-570.
10. Rosenfield RL, Deplewski D,. Role of androgens in the developmental biology of the pilosebaceous unit. Am J Med 1995; 98: 80S-88S.
11. Ristow HJ, Messmer TO,. Basic fibroblast growth factor and insulin-like growth factor-1 are strong mitogens for cultured mouse keratinocytes. J Cell Physiol 1988; 137: 277-284. (Pubitemid 19009024)
12. Krane JF, Murphy DP, Carter DM, Krueger JG,. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor 1/somatomedin C (IGF-1) on keratinocyte proliferation may be mediated by IGF-1 transmodulation of the EGF receptor. J Invest Dermatol 1991; 96: 419-424.
13. Silbergeld A, Litwin A, Bruchis S, Varsano I, Laron Z,. Insulin-like growth factor I (IGF-1) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clin Endocrinol (Oxf) 1986; 25: 67-74. (Pubitemid 16057665)
14. Downie MM, Sanders DA, Kealey T,. Modeling the remission of individual acne lesions in vitro. Br J Dermatol 2002; 147: 869-878. (Pubitemid 35365432)
15. Smith TM, Cong Z, Gilliland KL, Clawson GA, Thiboutot DM,. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 2006; 126: 1226-1232. (Pubitemid 43997901)
16. Kristiansen S, Endoh A, Casson P, Buster J, Hornsby P,. Induction of steroidogenic enzyme genes by insulin and IGF-1 in cultured adult human adrenocortical cells. Steroids 1997; 62: 258-265. (Pubitemid 27114621)
17. Deplewski D, Rosenfield RL,. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21: 363-392. (Pubitemid 32279645)
18. Cara JF, Rosenfield R, Furlanetto R,. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child 1987; 141: 562-564. (Pubitemid 17054176)
19. Deplewski D, Rosenfield RL,. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999; 140: 4089-4094. (Pubitemid 30647105)
20. Harper JC, Thiboutot DM,. Pathogenesis of acne: recent research advances. Adv Dermatol 2003; 19: 1-10. (Pubitemid 39297508)
21. Cappel M, Mauger D, Thiboutot D,. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005; 141: 333-338. (Pubitemid 40365449)
22. Aizawa H, Niimura M,. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995; 22: 249-252.
23. Vora S, Ovhal A, Jerajani H, Nair N, Chakrabortty A,. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol 2008; 159: 990-991.
24. Burton J, Libman L, Cunliffe WJ, Wilkinson R, Hall R, Shuster S,. Sebum excretion in acromegaly. Br Med J 1972; 1: 406-408.
25. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ,. Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta. Immunol Cell Biol 2000; 78: 74-79. (Pubitemid 30090992)
26. Holmes MD, Pollak MN, Willett WC, Hankinson SE,. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002; 11: 852-861. (Pubitemid 35014888)
27. Franks S,. Polycystic ovary syndrome. N Engl J Med 2003; 13: 853-861.
28. Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z,. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-1) in female patients with Laron syndrome. Clin Endocrinol (Oxf) 1998; 48: 81-87.
29. Laron Z, Klinger B,. Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol 1998; 138: 176-180. (Pubitemid 28131095)
30. Thiboutot D, Gilliland K, Light J, Lookingbill D,. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 1999; 135: 1041-1045. (Pubitemid 29430494)
31. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J,. Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol 1994; 130: 308-314. (Pubitemid 24107868)
32. Lucky AW,. Quantitative documentation of a premenstrual flare of facial acne in adult women. Arch Dermatol 2004; 140: 423-424. (Pubitemid 38469245)
33. Zouboulis CC, Xia L, Akamatsu H, et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998; 196: 21-31. (Pubitemid 28116033)
34. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F,. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998; 83: 2001-2005. (Pubitemid 28496328)
35. Laron Z, Avitzur Y, Klinger B,. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism 1995; 10 (Suppl 4): 113-118.
36. Powell D, Suwanichkul A, Cubbage M, DePaolis L, Snuggs M, Lee P,. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991; 266: 18868-18876. (Pubitemid 21908164)